THOUSAND OAKS, Calif. , Oct. 24, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) today announced that it will report its third quarter 2024 financial results on Wednesday, October 30, 2024 , after the close of the U.
S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.
m. ET . Participating in the call from Amgen will be Robert A.
Bradway , chairman and chief executive officer, and other members of Amgen's senior management team. Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.
amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.
The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today.
Amgen i.
